Drug interactions between ALK inhibitors and warfarin with concurrent use of bucolome: a case report

BACKGROUND: Alectinib, crizotinib, and ceritinib, are anaplastic lymphoma kinase-tyrosine kinase inhibitors (ALK-TKIs) that exhibit high protein binding, and their metabolism is associated with the cytochrome P450 (CYP) isoenzymes 2C9 or 3A4. The plasma protein binding rate of warfarin, which is use...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Takashi, Kunimoto, Yusuke, Kitagawa, Manabu, Asai, Yuichiro, Kimyo, Tomoko, Nakata, Hiromasa, Takahashi, Mamoru, Chiba, Hirofumi, Takahashi, Hiroki, Miyamoto, Atsushi, Fukudo, Masahide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150460/
https://www.ncbi.nlm.nih.gov/pubmed/37122027
http://dx.doi.org/10.1186/s40780-023-00282-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150460/
https://www.ncbi.nlm.nih.gov/pubmed/37122027
http://dx.doi.org/10.1186/s40780-023-00282-1

Ejemplares similares